Prescription Drug Pricing

About Prescription Drug Pricing

Prescription drugs should be affordable — but patients increasingly face challenges getting medication at fair prices. California’s hospitals are committed to ensuring the availability of lifesaving and life-changing medication. More than 180 California hospitals participate in the federal 340B Drug Pricing Program, which provides discount drugs to low-income patients, while many others participate in group purchasing organizations to lower costs. Solutions to rising drug prices must address drivers of cost, like supply shortages and lack of competition, and increase transparency for drug manufacturers.

CHA Issues Summary of Medicaid Drug Rebate Program Proposed Rule

CHA has issued a members-only summary, prepared by Health Policy Alternatives, Inc., of a proposed rule to implement policies in the Medicaid Drug Rebate Program related to legislative requirements addressing drug misclassification, as well as drug pricing and product data misreporting by manufacturers. The proposed rule also includes several other program integrity and program administration provisions. Comments are due to the Centers of Medicare & Medicaid Services (CMS) by 2 p.m. (PT) on July 25 and can be submitted online